38 results about "Topical Lotion" patented technology

Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include a halobetasol material comprising halobetasol or its pharmaceutically acceptable salts, esters, and solvates; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and / or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate. Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include 0.05% halobetasol propionate; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and / or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate.

The present invention is directed towards various topical protective formulations which may be used as an adjunct in preventing the spread of a broad range of sexually transmitted diseases. The product is intended to be used as a topical lotion, cream, emulsion, or the like. The film forming excipients and active ingredients in the following formulations have demonstrated unique skin protective barrier properties with enhanced persistence that inhibits transmission of sexually transmitted diseases.

Small fiber neuropathy is treated by topically administering to a subject in need thereof topically active quinoline compounds or pharmaceutically acceptable salts thereof under conditions effective to treat neuropathy in the subject. Glial cell-derived neurotrophic factor (GDNF) receptors are modulated with the subject active quinoline compounds, which may be formulated in topical lotions.

The invention provides an external lotion for treating vulvar lichen sclerosus, which is prepared from the following raw materials in parts by weight: Cnidium 20-30, Sophora flavescens 10-20, Kochia Radix 10-20, Chuanxiong 10- 20, White Fresh Skin 10-20, Cinnamon Branch 15-20, Psoralea 10-20, Forsythia 10-15, Wild Chrysanthemum 10-20, Cork 10-15, Cyanophora 10-18, Red Peony 10-20 , Comfrey 15‑30. The invention can relieve the symptoms of genital itching of the patient, restore the color of the vulva to normal, and reduce the range of lesions.

The invention relates to a Chinese medicinal combination for treating seborrhoeic dermatitis and is characterized in that the Chinese medicinal combination comprises an oral liquid made from the following herbs: 8-10 g of Gardenia jasminoides fruit, 4-6 g of Radix et Rhizoma Rhei, 8-10 g of Radix Scrophularia, 6-8 g of Asparagus cochinchinensis, 6-8 g of Rehmannia glutinosa, 8-12 g of Salvia miltiorrhiza, 6-9 g of Euryale ferox seed, 6-8 g of Schisandra chinensis, 8-12 g of Semen Coicis, 4-6 g of Fructus Amomi, 6-8 g of processed Rehmannia glutinosa, 6-8 g of Acanthopanax gracilistylus bark, 6-8 g of Sophora flavescens, 6-8 g of Radix Notoginseng, 4-6 g of Oldenlandia diffusa, 6-9 g of Poria cocos and 3-6 g of Radix Glycyrrhizae; and a topical lotion made from the following herbs: 20 g ofGardenia jasminoides fruit, 15 g of Radix et Rhizome Rhei, 10 g of Radix Notoginseng and 20 g of Oldenlandia diffusa. The Chinese medicinal combination has the effects of removing heat and toxic substances, removing heat from blood, invigorating the spleen and tonifying the kidney, eliminating dampness and relieving itching, and promoting blood circulation and removing blood stasis, and can promote functional activities of vital energy to promote production of qi, blood and body fluids and improve immunity. The Chinese medicinal combination has the advantages of good therapeutic effectiveness, short treatment course and high cure rate. The Radix et Rhizome Rhei is contraindicated for patients with spleen-stomach deficiency cold syndrome, manifested by poor appetite and loose stool.